The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Advanced Breast Cancer
Related studies linked through entity extraction aliases.
A Study of LXI-15029 in Patients With Advanced Malignant Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
"Curcumin" in Combination With Chemotherapy in Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Metronomic PLD in Patients With Primary Endocrine Resistant ABC
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of RC48-ADC in Subjects With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast
- Status
- UNKNOWN
- Phase
- N/A
Trial to Evaluate Efficacy and Safety of Pembrolizumab and Gemcitabine in HER2-negative ABC
- Status
- COMPLETED
- Phase
- PHASE2
Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2
- Status
- COMPLETED
- Phase
- PHASE1
Cambridge Brain Mets Trial 1
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Palbociclib Pharmacokinetics Study In Postmenopausal Chinese Women With ER (+), HER2 (-) Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Study of LDE225 (Sonidegib) in Combination With Docetaxel in Triple Negative (TN) Advanced Breast Cancer (ABC) Patients
- Status
- COMPLETED
- Phase
- PHASE1
Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2